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BRIEF CLINICAL REPORTSNovel mechanism of mitral regurgitation after lung transplantation
in a patient with scleroderma and pulmonary hypertensionChristian A. Bermudez, MD,a Rodolfo V. Rocha, MD,a William E. Katz, MD,b and
Yoshiya Toyoda, MD, PhD,a Pittsburgh, PaValvular complications after lung transplantation (LTx) are
rare. Mitral regurgitation (MR) after LTx has been associ-
ated only with acute endocarditis in immunosuppressed pa-
tients.1,2 We report an unusual case of severe MR diagnosed
in the late postoperative course of LTx, in the absence of
infection.CLINICAL SUMMARY
A 43-year-old woman with a history of scleroderma
complicated by advanced respiratory failure secondary
to pulmonary fibrosis and hypertension was considered
for LTx. Pulmonary artery pressures of 81 mm Hg (sys-
tolic) and 38 mm Hg (diastolic) with a transpulmonary
gradient of 38 mm Hg were associated with severe tricus-
pid regurgitation, severe right ventricular dilatation, and
moderate dysfunction. She underwent a successful double
LTx and a tricuspid valve annuloplasty using the De Vega
technique. Surgery was performed on cardiopulmonary
bypass with an allograft ischemic time of 405 minutes. In-
traoperative transesophageal echocardiography showed
preserved left ventricular function with moderate right
ventricular dilatation and no evidence of tricuspid regurgi-
tation or MR.
The patient experienced primary graft dysfunction
early postoperatively and required venoarterial extracor-
poreal membrane oxygenator (ECMO) support for 3
days, using central cannulation. ECMO weaning was
considered after recovery of lung function with a PAO2
of 76 mm Hg on 40% FIO2 and significant radiologic
improvement.
After ECMO weaning, several extubation attempts were
unsuccessful, despite adequate allograft function. A biopsy,
15 days after LTx, showed no acute cellular rejection or dif-
fuse alveolar damage. The patient had 2 episodes, on days
9 and 22 after transplant, of acute desaturation with a mod-From the Department of Cardiothoracic Surgerya and University of Pittsburgh Med-
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assumed to be related to primary graft dysfunction. Manual
ventilation and sedation allowed respiratory stabilization to
baseline. A third episode occurred 42 days after transplant,
with severe desaturation, and was associated with signifi-
cant pulmonary edema with frothy serosanguinous fluid.
The patient was hypoxemic, with a PAO2 of 35 mm Hg
and an elevated peak inspiratory pressure of 37 mm Hg, re-
quiring 100% FIO2 temporarily. A transthoracic echocar-
diogram revealed severe MR with centrally oriented
regurgitation, which had not been present in prior echocar-
diographic examinations, with normal valvular anatomy
but absence of coaptation between the anterior and the pos-
terior leaflets. No signs of endocarditis were found.
On the basis of the clinical course, we decided to per-
form a mitral valve repair 44 days after LTx. Via a right
anteroaxillary thoracotomy approach (previously used for
the transplant), on cardiopulmonary bypass, under ventric-
ular fibrillatory arrest, and through the left atrium,
a 26-mm Cosgrove-Edwards mitral band (Edwards Life-
sciences, Irvine, Calif) was placed, correcting the MR.
After an uneventful surgery, the patient recovered with
no complications and was removed from mechanical
ventilation 5 days later.DISCUSSION
This was a rare case of severe noninfectious MR compli-
cating the postoperative course of a double LTx. To our
knowledge, no similar case has been reported. The mecha-
nism underlying MR in this patient may be related to sub-
acute anatomic changes of the right and left ventricular
chambers with subsequent changes in the mitral annulus.
Another case of subacute progression of MR, perhaps
due to a similar mechanism, was previously seen at the Uni-
versity of Pittsburgh Medical Center after double LTx for
primary pulmonary hypertension and was treated conserva-
tively.
To corroborate this theory, we examined the left ventric-
ular and mitral valve size before and after LTx in our pa-
tient. The reduction in systolic pulmonary pressure, from
82 to 34 mm Hg, that occurred after LTx was associated
with a reduction in the size of the right ventricle, producing
inverse changes in the left ventricle and mitral annulus.
The mitral annular dimension, measured in diastole, in-
creased 0.9 cm (30%; from 2.17 to 3.08 cm) (Figure 1).
The diameter of the left ventricle in diastole increasedardiovascular Surgery c Volume 141, Number 1 e1
FIGURE 1. A, Pretransplant transthoracic echocardiogram with absence of MR on color Doppler. B, Posttransplant transthoracic echocardiogram with
dilatation of the mitral annulus and the presence of severe MR on color Doppler. C, Post-mitral valve repair transthoracic echocardiogram with absence
of MR on color Doppler. (Color Doppler is shown on the right side of each panel.) LA, Left atrium; LV, left ventricle.
Brief Clinical Reports1.4 cm (62%; from 2.26 to 3.65 cm) (Figure 2). These an-
atomic changes are consistent with the pathophysiologic
mechanism of MR—a clear lack of coaptation between
the anterior and posterior leaflets without leaflet prolapsee2 The Journal of Thoracic and Cardiovascular Surgeor chordal rupture. The implantation of a 26-mm band eas-
ily corrected the regurgitation, supporting this theory. No
signs of the mitral chordal or leaflet thickening, seen pre-
viously in a patient with scleroderma,3 or the early leftry c January 2011
FIGURE 2. Transthoracic echocardiogram pretransplant (A) and posttransplant (B), showing changes in right and left ventricular diameters. LA, Left
atrium; LV, left ventricle; RA, right atrium; RV, right ventricle.
Brief Clinical Reportsventricular dysfunction seen in patients undergoing LTx
for pulmonary hypertension4 were associated with the
mechanism of regurgitation in this case. The influence of
the tricuspid annuloplasty remains unclear, requiring fur-
ther analysis.CONCLUSIONS
We report this unusual case because it demonstrates
a rare mechanism of MR after LTx requiring surgical repair.
Close observation of left ventricular and mitral annular
anatomy is necessary after LTx in patients with severe pul-
monary hypertension. Inverse remodeling of the left-sidedFrom the Department of Thoracic and Cardiovascular Surgery, Heart and Vascular In-
stitute, Cleveland Clinic, Cleveland, Ohio.
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The Journal of Thoracic and Cstructures could be associated with clinically relevant,
new-onset MR.
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1999;18:304-9.Third-time lung transplantation in a patient with cystic fibrosisNakul Vakil, MD, David P. Mason, MD, James J. Yun, MD, PhD, Sudish C. Murthy, MD, PhD,
Marie M. Budev, DO, and Gosta B. Pettersson, MD, PhD, Cleveland, OhioRespiratory failure is the leading cause of death in patients
with cystic fibrosis (CF), and lung transplantation (LTx) is
the only treatment option for patients with end-stage dis-
ease. Unfortunately, the long-term success of LTx is limited
by the development of bronchiolitis obliterans syndrome
(BOS), and retransplantation (re-LTx) for these patients is
infrequent and controversial.1-4 Concerns include (1) the
technical difficulty of re-LTx; (2) immunologic barriers
imparting worse survival in patients whose first graftsardiovascular Surgery c Volume 141, Number 1 e3
